InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hombach Robert J., Director. Officer active across 7 companies, notably Biomarin Pharmaceutical INC. In total, 18 reports have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €217k. Activity tracked since 25 May 2021. The latest transaction was filed on 12 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Hombach Robert J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
45,000 shares@ US$4.9744Common StockSEC:0000947871-26-000786:0
Canonical exit: 10 Nov 2026 (T+90)
13,000 sharesCommon StockSEC:0001193125-26-280175:0
Canonical exit: 20 Sept 2026 (T+90)
7,490 shares0Common StockSEC:0001628280-26-040916:0
2,577 shares0Common Stock par value $0.01 per shareSEC:0001496182-26-000002:0
22,841 shares0Common StockSEC:0000947871-26-000164:0
6,650 shares0Common StockSEC:0001048477-25-000074:0
2,844 shares0Common Stock par value $0.01 per shareSEC:0000950170-25-034740:0
13,839 shares0Common StockSEC:0000947871-25-000184:0
4,720 shares0Common StockSEC:0001048477-24-000106:0
11,455 shares0Common StockSEC:0000947871-24-000108:0
4,190 shares0Common StockSEC:0001209191-23-031971:0
6,979 shares0Common StockSEC:0001209191-23-008441:0
4,980 shares0Common StockSEC:0001567619-22-011794:0
6,024 shares0Common StockSEC:0001209191-22-023177:0
5,400 shares@ US$2.4025.0% of flowCommon StockSEC:0001415889-21-005223:0
Canonical exit: 9 Feb 2022 (T+90)
5,400 shares@ US$2.40100.0% of flowCommon StockSEC:0001415889-21-005202:0
Canonical exit: 9 Feb 2022 (T+90)
1,308 shares0Common StockSEC:0001170010-21-000150:0
5,120 shares0Common StockSEC:0001567619-21-011309:0
18 of 18 declarations
About Hombach Robert J.
HOMBACH ROBERT J. is Administrateur and a declarant, with 17 filings in total. Across the 17 sampled filings, the reported buy amount is 22567 EUR and the reported sell amount is 0, covering the period from 2021-05-27 to 2026-06-24. The companies mentioned are Biomarin Pharmaceutical INC, Embecta Corp., Henry Schein INC, Aptinyx Inc., Seaport Therapeutics, Inc. and CARMAX INC, and the stated transaction nature is Attribution.
